SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-013429
Filing Date
2023-05-10
Accepted
2023-05-10 09:20:13
Documents
14
Period of Report
2023-05-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20230509c_8k.htm   iXBRL 8-K 26906
2 EXHIBIT 99.1 - PRESS RELEASE - WARRANT REDEMPTION ex_517676.htm EX-99.1 11945
  Complete submission text file 0001437749-23-013429.txt   175544

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plse-20230510.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20230510_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20230510_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20230510_pre.xml EX-101.PRE 11688
8 EXTRACTED XBRL INSTANCE DOCUMENT plse20230509c_8k_htm.xml XML 2557
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 23904606
SIC: 3841 Surgical & Medical Instruments & Apparatus